14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.779 15 days ( -3.87 % )
Last Price $0.81 -3.55 %
High/ Low $0.80 - $0.84 2.05%
Chg 7 Days -2.19 % $0.83 $0.81
Chg 30 Days -25.67 % $1.09 $0.81
Chg 12 mos -28.30 % $1.13 $0.81
Trend - 3 mos 31.14 % Width: 60.44 %
Trend - 12 mos -41.57 % Width: 1,097.53 %
Pred. range - 3 mos $1.02 - $1.63 25.74 % - 101.73 %
Pred. range - 12 mos $0.0617 - $0.739 -92.38 % - -8.80 %
Short MA avg 3 mos Buy May 01, 2024 - 3 days
Long MA avg 3 mos Sell Apr 12, 2024 - 16 days
Short/Long MA avg 3 mos Sell Apr 17, 2024 - 13 days
Short MA avg 12 mos Sell Apr 12, 2024 - 16 days
Long MA avg 12 mos Buy Feb 15, 2024 - 55 days
Short/Long MA avg 12 mos Buy Feb 22, 2024 - 51 days
Pivot Short Sell Apr 11, 2024 - 17 days
Bollinger Buy Dec 27, 2023 - 89 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Viracta Therapeutics, Inc.

Viracta Therapeutics. Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as we... VIRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT